35
Participants
Start Date
July 7, 2022
Primary Completion Date
June 13, 2024
Study Completion Date
February 28, 2027
Adaptive radiotherapy according to UPRATE protocol
According to previously reported STAMPEDE trial (Parker et al.), patients will be treated with 6 weekly fractions of 6 Gy. According to local protocol the target will consist of prostate and entire seminal vesicles. Additional CT-scans will be made prior to and directly following each fraction. For more details, see study description
Erasmus Medical Centre, Rotterdam
Lead Sponsor
Erasmus Medical Center
OTHER